Proceeds from the fresh issue will be used towards payment of outstanding purchase consideration to the promoter for the spin-off of the API business and funding the capital expenditure requirements.
Consolidated revenue from operations of the company stood at Rs 789.99 crore for the quarter under consideration.
The board of the company also approved a proposal for enhancing the capacity of the Jajpur facility in Odisha from 1.10 MTPA to 2.10 MTPA (million tonne per annum) at an investment cost of Rs 2,150 crore, JSL said.
As India continues on its growth journey, the fund house aspires to be a wealth creator for every Indian, with an audacious vision to be the most respected asset manager in the world, Munot added.
Big technology stocks were the biggest weight on the market as China increases restrictions on internet apps and other companies.
The six firms, which had filed their respective preliminary IPO papers with the markets regulator between May and June, obtained their observations during July 19-23, an update with SEBI showed on Monday.
Under the terms of the deal, Biocon Biologics will get access to the clinical and non-clinical data from Adagioâs EUA submission to the U.S. Food and Drug Administration to seek approvals in the emerging markets.
Total income declined 16 percent to Rs 2,567 crore in the quarter from Rs 3,069 crore in the year-ago period, Mahindra Finance said in a release.
Careers in technology and other parts of the finance world promise better hours and more flexibility
Dr Kantilal Hastimal Sancheti has performed more than 50,000 surgeries, developed the countryâs first knee implant, worked for more than 56 years, and is now writing a book. He shares his journey with Moneycontrol